LivaNova LIVN
$90.73 −$1.34 (-1.46%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $90.73 0.00%
Open$91.50
Prev close$92.07
Day range$90.15 – $93.16
Volume536.7K
Market cap$5.00B
P/E (TTM)26.0
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$393.15M+9.9% YoY
Operating profit$28.43M-47.4% YoY
Net profit$34.29M+28.0% YoY
Diluted EPS$0.11-77.6% YoY
Free cash flow$42.89M-31.0% YoY
Operating cash flow$73.66M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin67.8%
Operating margin10.7%
Net margin13.0%
Return on equity15.5%
Return on assets7.4%
Return on invested capital12.2%
Current ratio1.46
Liabilities / assets49.4%
Cash & investments$563.47M
Total debt$347.88M
Net cash (debt)$215.58M
Free cash flow / sales8.6%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $393.15M | $390.59M | $362.26M | $1.39B | $360.92M |
| Total Operating Revenue | $393.15M | $390.59M | $362.26M | $1.39B | $360.92M |
| Cost of Revenue | $128.10M | $116.92M | $118.51M | $448.18M | $121.15M |
| Gross Profit | $265.05M | $273.67M | $243.75M | $939.87M | $239.77M |
| Operating Expense | $236.63M | $224.19M | $202.28M | $740.48M | $197.20M |
| Selling and Admin Expenses | $154.93M | $158.13M | $143.57M | $548.81M | $143.37M |
| Research & Development | $47.69M | $53.66M | $58.70M | $185.76M | $52.12M |
| Other Operating Expenses | $34.01M | $12.40M | $15,000.00 | $5.90M | $1.71M |
| Operating Profit | $28.43M | $49.48M | $41.47M | $199.39M | $42.58M |
| Net Non-Operating Interest Income (Expense) | -$4.06M | -$3.35M | -$4.74M | -$30.30M | -$3.75M |
| Non-Operating Interest Income | $3.90M | $3.83M | $3.55M | $18.98M | $4.46M |
| Non-Operating Interest Expense | $7.95M | $7.18M | $8.29M | $49.29M | $8.21M |
| Other Income (Expense) | $22.41M | -$27.66M | -$9.25M | -$389.87M | -$11.20M |
| Gain on Sale of Security | $22.41M | -$41.41M | -$8.12M | -$25.34M | -$11.60M |
| Special Income (Charges) | $0.00 | $13.65M | -$1.13M | -$365.19M | -$261,000.00 |
| -Less:Write Off | $0.00 | $0.00 | $1.13M | $1.11M | $0.00 |
| Pretax Profit | $46.77M | $18.48M | $27.49M | -$220.78M | $27.63M |
| Tax | $12.40M | -$90.20M | $4.34M | $21.64M | -$3.28M |
| $84,000.00 | $114,000.00 | $851,000.00 | $51,000.00 | $10,000.00 | |
| Net Profit | $34.29M | $108.57M | $22.29M | -$242.47M | $30.91M |
| Profit from Continuing Operations | $34.29M | $108.57M | $22.29M | -$242.47M | $30.91M |
| Net Income to Parent Company | $34.29M | $108.57M | $22.29M | -$242.47M | $30.91M |
| Net Income to Common Stockholders | $34.29M | $108.57M | $22.29M | -$242.47M | $30.91M |
| Basic EPS | $0.62 | $1.98 | $0.41 | -$4.45 | $0.57 |
| Diluted EPS | $0.11 | $1.93 | $0.40 | -$4.45 | $0.56 |
| -Gain on Sale of Property/Plant/Equipment | – | $13.65M | – | $4.13M | – |
| Other Non-Operating Income (Expenses) | – | $105,000.00 | – | $664,000.00 | – |
| -Less:Impairment of Capital Assets | – | – | – | $0.00 | – |
| -Less:Other Special Charges | – | – | – | $368.20M | $4.39M |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $2.71B | $2.64B | $2.52B | $2.61B | $2.61B |
| Total Current Assets | $1.08B | $1.03B | $1.01B | $1.10B | $1.10B |
| Cash and Cash Equivalents & Short-Term Investments | $563.47M | $516.62M | $539.71M | $635.55M | $635.55M |
| -Cash and Cash Equivalents | $563.47M | $516.62M | $539.71M | $635.55M | $635.55M |
| Receivables | $282.65M | $274.17M | $270.55M | $264.59M | $264.59M |
| -Accounts Receivable | $236.37M | $231.30M | $229.27M | $215.99M | $215.99M |
| -Taxes Receivable | $46.27M | $42.87M | $41.27M | $48.61M | $48.61M |
| Inventory | $177.88M | $172.61M | $165.50M | $164.70M | $164.70M |
| Other Current Assets | $58.85M | $61.64M | $38.48M | $36.77M | $36.77M |
| Total Non-Current Assets | $1.63B | $1.62B | $1.50B | $1.50B | $1.50B |
| Net PPE | $350.00M | $330.05M | $310.02M | $298.12M | $298.12M |
| -Gross PPE | $350.00M | $330.05M | $310.02M | $540.33M | $540.33M |
| Investments and Advances | $16.80M | $15.27M | $18.49M | $20.29M | $20.29M |
| Financial Assets | $52.59M | $57.29M | $38.28M | $36.55M | $36.55M |
| Goodwill and Other Intangible Assets | $989.54M | $996.15M | $1.01B | $1.02B | $1.02B |
| -Goodwill | $778.81M | $779.14M | $785.59M | $792.84M | $792.84M |
| -Other Intangible Assets | $210.73M | $217.00M | $224.56M | $229.96M | $229.96M |
| Non-Current Deferred Assets | $194.45M | $198.75M | $109.82M | $110.98M | $110.98M |
| Other Non-Current Assets | $26.90M | $18.31M | $15.37M | $15.69M | $15.69M |
| Total Liabilities | $1.34B | $1.32B | $1.31B | $1.41B | $1.41B |
| Total Current Liabilities | $740.19M | $707.00M | $762.48M | $808.07M | $808.07M |
| Payables | $137.75M | $127.41M | $140.85M | $130.29M | $130.29M |
| -Accounts Payable | $106.91M | $103.39M | $99.15M | $97.16M | $97.16M |
| -Total Tax Payable | $30.84M | $24.01M | $41.70M | $33.13M | $33.13M |
| Current Accrued Expenses | $72.28M | $75.25M | $72.52M | $68.85M | $68.85M |
| Short-Term Debt and Capital Lease Obligation | $13.08M | $12.37M | $11.59M | $40.26M | $40.26M |
| -Current Debt | $3.90M | $3.58M | $2.63M | $31.47M | $31.47M |
| -Current Capital Lease Obligation | $9.19M | $8.79M | $8.96M | $8.79M | $8.79M |
| Current Provisions | $31.73M | $24.07M | $14.01M | $17.87M | $17.87M |
| Current Deferred Liabilities | $13.64M | $13.86M | $16.20M | $11.51M | $11.51M |
| Other Current Liabilities | $383.79M | $385.08M | $449.69M | $446.37M | $446.37M |
| Total Non-Current Liabilities | $600.86M | $608.54M | $542.55M | $597.99M | $597.99M |
| Long Term Debt and Capital Lease Obligation | $343.99M | $339.58M | $331.86M | $393.51M | $393.51M |
| -Long Term Debt | $295.19M | $289.91M | $285.16M | $345.19M | $345.19M |
| -Long Term Capital Lease Obligation | $48.79M | $49.67M | $46.70M | $48.33M | $48.33M |
| Derivative Product Liabilities | $124.75M | $152.90M | $93.25M | $83.90M | $83.90M |
| Non-Current Deferred Liabilities | $7.74M | $9.31M | $6.81M | $9.59M | $9.59M |
| Employee Benefits | $13.90M | $13.97M | $13.11M | $13.57M | $13.57M |
| Other Non-Current Liabilities | $110.47M | $92.77M | $97.52M | $97.41M | $97.41M |
| Total Equity | $1.37B | $1.33B | $1.21B | $1.20B | $1.20B |
| Stockholders' Equity | $1.37B | $1.33B | $1.21B | $1.20B | $1.20B |
| Capital Stock | $84.60M | $84.60M | $84.56M | $84.56M | $84.56M |
| -Common Stock | $84.60M | $84.60M | $84.56M | $84.56M | $84.56M |
| Additional Paid-In Capital | $2.28B | $2.27B | $2.25B | $2.25B | $2.25B |
| Retained Earnings | -$980.56M | -$1.01B | -$1.12B | -$1.15B | -$1.15B |
| Less: Treasury Stock | -$694,000.00 | -$732,000.00 | -$1.17M | -$1.17M | -$1.17M |
| Gains/Losses Not Affecting Retained Earnings | -$15.25M | -$14.39M | -$3.40M | $7.33M | $7.33M |
| Restricted Cash | – | – | – | $0.00 | $0.00 |
| -Accumulated Depreciation | – | – | – | -$242.21M | -$242.21M |
| -Available for Sale Securities | – | – | – | $3.00M | $3.00M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $73.66M | $66.59M | $15.22M | $254.34M | $82.40M |
| Net cash flow from continuing operations | $73.66M | $66.59M | $15.22M | $254.34M | $82.40M |
| Net Income from Continuing Operations | $34.29M | $108.57M | $22.29M | -$242.47M | $30.91M |
| Gain/Loss from Continuing Operations | -$22.82M | $29.63M | $9.80M | -$8.38M | $5.96M |
| Depreciation & Depletion & Amortization | $17.79M | $18.20M | $15.60M | $59.63M | $14.71M |
| Deferred Tax | $3.05M | -$91.77M | $1.82M | $455,000.00 | -$3.61M |
| Other Non-Cash Items | $8.97M | $3.31M | $16.60M | $34.10M | $8.95M |
| Change in Working Capital | -$11.15M | -$18.23M | -$60.29M | $369.97M | $19.13M |
| -Change in Receivables | -$5.34M | -$2.48M | -$14.67M | -$10.71M | -$4.88M |
| -Change in Inventory | -$5.28M | -$8.60M | -$1.55M | -$5.29M | $2.81M |
| -Change in Payables and Accrued Expense | $15.63M | -$4.55M | -$37.06M | -$17.04M | $32.59M |
| -Change in Other Current Assets | -$8.33M | -$13.25M | -$4.20M | $38.54M | -$12.04M |
| -Change in Other Current Liabilities | $0.00 | $0.00 | $0.00 | $365.55M | $1.74M |
| Net cash flow from investing | -$23.11M | -$31.92M | -$14.58M | -$72.91M | -$30.26M |
| Net Cash Flow from Continuing Investing Activities | -$23.11M | -$31.92M | -$14.58M | -$72.91M | -$30.26M |
| Net PPE Purchase and Sale | -$30.77M | -$31.55M | -$14.29M | -$81.05M | -$32.23M |
| Net Investment Purchase and Sale | $6.95M | – | – | $857,000.00 | -$5.67M |
| Net Other Investing Changes | $712,000.00 | -$367,000.00 | -$290,000.00 | $7.28M | $7.64M |
| Financing Cash Flow | -$2.92M | -$56.45M | -$94.25M | -$285.66M | -$62.88M |
| Net Cash Flow from Continuing Financing Activities | -$2.92M | -$56.45M | -$94.25M | -$285.66M | -$62.88M |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | -$95.94M | -$280.93M | -$64.11M |
| Net Other Financing Charges | $8.81M | -$56.45M | $1.69M | -$338,000.00 | $2.00M |
| Ending Cash Balance | $563.47M | $516.62M | $539.71M | $635.55M | $635.55M |
| Net Change in Cash | $47.64M | -$21.78M | -$93.61M | -$104.23M | -$10.75M |
| Beginning Cash Balance | $516.62M | $539.71M | $635.55M | $723.56M | $646.08M |
| Effect of Exchange Rate Changes | -$788,000.00 | -$1.31M | -$2.24M | $16.23M | $219,000.00 |
| Free Cash Flow | $42.89M | $35.04M | $926,000.00 | $173.29M | $50.16M |
| -Change In Other Working Capital | – | $10.66M | -$2.82M | -$1.09M | – |
| Proceeds from Stock Option Exercised | – | – | – | -$4.40M | -$770,000.00 |
No comments yet — be the first to weigh in on LIVN.
Sign in to join the discussion.